Pharmaceutical Technologies

The following section deals with manufacturing technologies of Pharmaceuticals and up-to-date pharmaceutical equipment

Servier Australia and BioCurate Agreed to Share Expertise to Accelerate the Discovery of New Drugs

Servier Australia, the subsidiary of Servier Group, an international pharmaceutical company, and BioCurate, a joint venture company of Monash University and The University of Melbourne with support fr...

The Power of Steam: How to Remove Residues of Collagen from Metal Bowls

The pharmaceutical industry faces the challenge of developing an effective washing strategy for removing collagen from metal bowls. Fedegari performed trials in its R&D laboratory located in Albuz...
biotech

Erytech Received $57m from SQZ Biotechnologies for New Immune Modulating Therapies Development

Erytech Pharma has inked a deal with SQZ Biotechnologies Inc. to develop new immune modulating therapies. Under the agreement, Erytech will licence the rights to use its ERYCAPS platform to SQZ, whic...
gilead sciences

Cooperation on Development of Immuno-Oncology Therapies Announced by Gilead and Carna Biosciences

Gilead Sciences, Inc. and Carna Biosciences Inc. announced that the companies have entered into a research and development collaboration to develop and commercialize small molecule compounds in immuno...

Cytel and Axio to Create Industry Leader in Analytical Solutions for Drug Development

Cytel Inc., the leading global provider of innovative analytical software and services to the life sciences industry, and Axio Research, a premier provider of biostatistics to pharmaceutical, biotechn...

New Biotechnology Company Launched by GT Healthcare

GT Apeiron Therapeutics, a novel biotechnology company, was launched with the backing from GT Healthcare and associated investors. The company also entered into a drug discovery collaboration with ...

Novel and First-in-Cass Drug Design Technology

Cyclica, a leading biotechnology company that commercialized Ligand Express announced its novel, first-in-class drug design technology, Ligand Design on stage at the Collision Conference in Toronto. ...

Teijin and AMED Agreed Partnership to Develop Drugs for Frail

Teijin Limited announced that it has signed a research and development agreement with the Japan Agency for Medical Research and Development (AMED) to form an industry-government-academia partnership t...

Video

Expert opinion